Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$415K Buy
3,515
+400
+13% +$46.2K 0.01% 1110
2026
Q1
$372K Buy
3,115
+64
+2% +$8.39K 0.01% 571
2025
Q4
$401K Buy
3,051
+34
+1% +$4.89K 0.01% 974
2025
Q3
$445K Sell
3,017
-153
-5% -$21.2K 0.01% 1040
2025
Q2
$410K Buy
3,170
+58
+2% +$7.02K 0.01% 998
2025
Q1
$372K Buy
+3,112
New +$386K 0.01% 872
2020
Q4
Sell
-2,592
Closed -$218K 891
2020
Q3
$218K Buy
+2,592
New +$202K 0.02% 648

Other funds holding XYL

J.W. Cole Advisors's XYL Position: Q2 2026 in Review

J.W. Cole Advisors increased its Xylem (XYL) stake by 13% in Q2 2026, buying an estimated $46.2K and bringing the position to 3,515 shares worth $415K. The position accounts for 0.01% of the portfolio, ranked #1110.

J.W. Cole Advisors first reported a position in XYL in Q3 2020 and has held it in 7 quarters since. The position peaked at $445K in Q3 2025. 431 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • J.W. Cole Advisors held 3,515 shares of Xylem worth $415K as of Q2 2026.
  • J.W. Cole Advisors bought 400 Xylem shares in Q2 2026, an estimated $46.2K.
  • Xylem made up 0.01% of J.W. Cole Advisors's portfolio in Q2 2026, its #1110 holding.
  • J.W. Cole Advisors first reported a position in Xylem in Q3 2020 and has held it in 7 quarters since.
  • J.W. Cole Advisors's Xylem position peaked at $445K in Q3 2025.
  • 431 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.